RBD-displaying OMV nanovaccine boosts immunity against SARS-CoV-2.

J Nanobiotechnology · 2025 · PMC11807311 · PMID 39923096

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although this trend did not reach statistical significance, it provides preliminary indications of a potential enhancement in splenic T cell activation.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.